Search

12 Jul 2024: Franklin of the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute is developing a new regenerative therapy for multiple sclerosis (MS). ... for drug discovery and development are invited to contact Cambridge Enterprise, the

12 Jul 2024: a variety of fascinating, often exciting consultancy projects./p /div /blockquote /div pHugh relies on Cambridge Enterprise’s Consultancy Services team to handle all the administrative work surrounding these projects. ... noise of the bells!/p pAs Hugh

12 Jul 2024: enterprise.cam.ac.uk"Cambridge Enterprise/a./p preA possible new method for treating pancreatic cancer which enables the body’s immune system to attack and kill cancer cells has been ... cite/div /div /blockquote /div pInitial tests of the combined

12 Jul 2024: cam.ac.uk/case-studies/xampla-pioneering-a-plastic-free-future/ Tegen Amos Tue, 06 Feb 2024 17:12:02 0000 Amadeus Capital Partners B Corp status cambridge angels CIECH Ventures ... care-company-nobacz-healthcare-ltd-closes-2-7m-seed-round/ Jo Tramontin

12 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... a appeared first on a

12 Jul 2024: by University of Cambridge researchers/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p preThe U.S. ... the animal antibody with human equivalents – for the drug to be successful in humans.

12 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... This drug has taken decades to develop, and we applaud the team at Cambridge for all their work in making it a reality.

12 Jul 2024: rel="noopener noreferrer"Cycle Pharmaceuticals/a, a Cambridge-based company, the researchers identified six known molecules that they thought might inhibit the PARP enzymes. ... were going to cure hardening of the arteries.”/p pThe technology has been

12 Jul 2024: Andrew Walsh/cite/div /div /blockquote /div p“XO1 has made great progress with Ichorcumab,” said Dr Andrew Walsh, a technology manager at Cambridge Enterprise. ... Enterprise/a./p preThe University laboratories at the Stevenage Bioscience Catalyst,

12 Jul 2024: collaborate-to-identify-new-druggable-targets/"PhoreMost and The Wistar Institute collaborate to identify new druggable targets/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge ... convert this information rapidly into novel

12 Jul 2024: by University of Cambridge researchers/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p preThe U.S. ... the animal antibody with human equivalents – for the drug to be successful in humans.

12 Jul 2024: met with the Cambridge Vice-Chancellor Professor Sir Leszek Borysiewicz last Friday (2 March), before a day-long seminar involving academics from both institu./p pThe post a ... strong-links-with-brazil/"Event highlights strong links with Brazil/a

12 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... Concept Funding from Cambridge Enterprise Seed Funds in

12 Jul 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... This drug has taken decades to develop, and we applaud the team at Cambridge for all their work in making it a reality.

12 Jul 2024: for very young companies,” said Dr Anne Dobrée, Head of Seed Funds at Cambridge Enterprise. ... hosting the prestigious European Entrepreneurship Colloquium this year at the University of Cambridge,” the Vice-Chancellor commented.

12 Jul 2024: Eventually, however, performance degrades and the batteries must be recycled, as lead is highly toxic to plants and animals./p div class="stat alignright"The Cambridge process uses about 8% of ... Enecsys secures £25m investment/a appeared first on a

12 Jul 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... Cambridge, funding a post-doctoral researcher in Martin’s laboratory to work on the design and construction of the

26 Mar 2024: choose whether to ‘opt-in’ or ‘opt-out’ of working with Cambridge Enterprise. ... How does Cambridge Enterprise decide whether to take my idea into its portfolio?

12 Jul 2024: At Cambridge Enterprise, we work with a number of companies that license University research. ... Cambridge, is developing the next generation of WSS thatis universal, flexible, and software upgradable.

12 Jul 2024: Steve Jackson, who is the University of Cambridge and Cancer Research Uk Professor of Biology and Head of Cancer Research UK (CRUK) Laboratories at the Gurdon institute. ... Steve Jackson, who is the University of Cambridge and Cancer Research UK